SMAD4 and glioma: To further validate that SMC4-mediated glioma cell aggressiveness takes place through TGFβ activation, we blocked the TGFβ pathway in SMC4-overexpressing cells by transfecting the cells with Smad4 siRNA or the TGFβ inhibitor LY2157299 monohydrate.